The Discounted Cash Flow (DCF) valuation of Vascular Biogenics Ltd (VBLT) is (51.24) USD. With the latest stock price at 0.16 USD, the upside of Vascular Biogenics Ltd based on DCF is -32947.9%.
Based on the latest price of 0.16 USD and our DCF valuation, Vascular Biogenics Ltd (VBLT) is a sell. selling VBLT stocks now will result in a potential gain of 32947.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.9% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (128.02) - (32.55) | (51.24) |
| Upside | -82164.8% - -20964.0% | -32947.9% |